<p>Deal with Singapore’s MuseCell Innovations could bring $300 million in business and 200 jobs to Celularity’s cell platform. Deals in cell therapy tend to get announced in two flavors: the kind built around a single drug, and the kind built around infrastructure. This unglamorous plumbing decides whe</p>